Conmed (CNMD) Accounts Payables (2010 - 2026)

Conmed has reported Accounts Payables for 17 years, with the latest figure at $105.4 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 10.12% year-over-year to $105.4 million; the trailing twelve-month figure through Mar 2026 stood at $105.4 million (up 10.12% YoY), and the FY2025 full-year result was $93.6 million, down 8.41% from the prior year.
• Accounts Payables for Q1 2026 stood at $105.4 million, up from $93.6 million in the prior quarter.
• The five-year high for Accounts Payables was $107.1 million in Q3 2025, with the low at $67.5 million in Q1 2022.
• Historically, Accounts Payables has averaged $89.8 million across 5 years, with a median of $93.6 million in 2025.
• Annual changes were most pronounced in 2022 — Accounts Payables surged 59.3% — and 2025, when it declined 8.41%.
• Conmed's Accounts Payables stood at $73.4 million in 2022, then climbed by 20.21% to $88.2 million in 2023, then grew by 15.9% to $102.2 million in 2024, then fell by 8.41% to $93.6 million in 2025, then rose by 12.57% to $105.4 million in 2026.
• The last three Accounts Payables figures came in at $105.4 million (Q1 2026), $93.6 million (Q4 2025), and $107.1 million (Q3 2025), per Business Quant data.